Recombinant Transmembrane Domain-Deficient STING as Biomimetic Protein Carrier for cGAMP Enhanced Cancer Immunotherapy
Invention type: Technology
/
Case number: #25012
Researchers
Departments: David H Koch Institute for Integrative Cancer Res, Office of the Provost, Department of Biological Engineering
Technology Areas: Biotechnology: Synthetic Biology / Therapeutics: Proteins & Antibodies, Vaccines
Impact Areas: Healthy Living
-
engineering immune checkpoint blockade nanobody-sting delta-tm fusion protein as a versatile treatment for solid tumor cancers
United States of America | Published application -
recombinant transmembrane domain-deficient sting as biomimetic protein carrier for cgamp enhanced cancer immunotherapy
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.